Press Releases | Medtronic

Month Year

Email alerts

Jul 27, 2010

Medtronic's AMPLIFY(TM) rhBMP-2 Matrix Receives Positive Votes from FDA Advisory Panel on All Three Key Questions: Safety, Effectiveness and Benefit/Risk

New biologic bone graft product demonstrated superior fusion rates compared to current standard of care for complex fusion procedures of the lower spine in the pivotal clinical trial

MINNEAPOLIS, Jul 27, 2010 (BUSINESS WIRE) -- The U.S. Food and Drug Administration (FDA) Orthopaedic and Rehabilitation Devices Panel today voted 9 for and 4 against (1 abstention) on safety and...
Jul 13, 2010

Medtronic Partners with Patient Advocacy Groups to Launch Educational Campaign to Raise Awareness of Spasticity

Release Your Potential Campaign Encourages People to Take Control of Severe Spasticity and Seek Treatment

MINNEAPOLIS, Jul 13, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the launch of an educational campaign, called Release Your PotentialSM, that is designed to raise awareness...
Jul 2, 2010

Physio-Control Field Correction to LIFEPAK(R) 20/20e Defibrillator/ Monitors

MINNEAPOLIS, Jul 02, 2010 (BUSINESS WIRE) -- Physio-Control, Inc., a wholly owned subsidiary of Medtronic, Inc., (NYSE: MDT), announced the company's recent initiation of a field correction on...
Jun 30, 2010

Medtronic Receives CE Mark for Ensura MRI(TM) SureScan(TM) Pacing System Approved for Use in MRI Machines as Labeled

New Option in Second-Generation Pacing System Available in Select European Geographies Features Exclusive Technology and Allows Access to Critical Diagnostic Tool

MINNEAPOLIS, Jun 30, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today the company received CE (Conformité Européenne) Mark for Ensura MRI(TM) SureScan(TM) pacing system....
Jun 29, 2010

STAR 3 Trial Results Confirm Medtronic's Sensor-Augmented Insulin Pump Therapy Achieves Better Glucose Control Than Daily Insulin Injections in People with Diabetes

Results of Study Published in NEJM and Presented at ADA Could Redefine the Standard of Care for People with Type 1 Diabetes

MINNEAPOLIS, Jun 29, 2010 (BUSINESS WIRE) -- In the longest and largest randomized, controlled study of sensor-augmented insulin pump therapy in type 1 diabetes, adult and pediatric patients using...
Jun 25, 2010

Medtronic Begins Enrollment in ASPIRE Pivotal Study of Low Glucose Suspend Integrated System

Semi-Closed Loop System Designed to Reduce Severity and Duration of Hypoglycemia

MINNEAPOLIS, Jun 25, 2010 (BUSINESS WIRE) --Demonstrating its dedication to close the loop for diabetes management, Medtronic, Inc. (NYSE:MDT) today announced that the first patient has been...
Jun 25, 2010

Medtronic Launches New Midas Rex(R) High-Speed Electric Drill for Surgeons

New Surgical Drill Offers Power and Maneuverability with Easy Fingertip Control

MINNEAPOLIS, Jun 25, 2010 (BUSINESS WIRE) --Medtronic, Inc.(NYSE: MDT) today announced availability of the company's new Midas Rex(R) Legend(R) EHS Stylus Touch(TM) high-speed electric drill for...
Jun 24, 2010

Medtronic Increases Cash Dividend for First Quarter of Fiscal Year 2011

MINNEAPOLIS, Jun 24, 2010 (BUSINESS WIRE) --The board of directors of Medtronic, Inc. (NYSE:MDT), today approved a cash dividend of $0.225 per share of the company's common stock; an increase of 9...
Jun 23, 2010

Medtronic Reiterates FY11 Guidance

MINNEAPOLIS, Jun 23, 2010 (BUSINESS WIRE) --Gary Ellis, senior vice-president and chief financial officer at Medtronic, Inc. (NYSE: MDT) today reiterated fiscal year 2011 revenue and diluted...
Jun 22, 2010

Medtronic Announces 2010 ''Global Heroes''

Distance Runners from Around the World Who Benefit from Medical Technology to Run this Fall in Medtronic Twin Cities Marathon Events

MINNEAPOLIS, Jun 22, 2010 (BUSINESS WIRE) --Twenty-five long-distance runners who benefit from medical technology have been selected as 2010 Global Heroes by Twin Cities In Motion, the non-profit...

Show per page